ARPEGE, the french consortium which gathers Antabio, bioMérieux, Bpifrance, HCL and TSE, awarded public funding of close to €9 million to fight antibiotic resistance.
ARPEGE is the french acronym for Economic, diagnostic and therapeutic approach to antibiotic resistance.
This consortium will become important for public health, using a ground-breaking model to provide a framework for innovation and to strengthen the ability of healthcare systems.
Read the press release
Illustration by Hal Gatewood on Unsplash
